Hunan Jiudian Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hunan Jiudian Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥367.3M, which brings its debt-to-equity ratio to 15.4%. Its total assets and total liabilities are CN¥3.2B and CN¥857.7M respectively. Hunan Jiudian Pharmaceutical's EBIT is CN¥537.7M making its interest coverage ratio 44.8. It has cash and short-term investments of CN¥710.0M.
Key information
15.4%
Debt to equity ratio
CN¥367.34m
Debt
| Interest coverage ratio | 44.8x |
| Cash | CN¥710.04m |
| Equity | CN¥2.38b |
| Total liabilities | CN¥857.67m |
| Total assets | CN¥3.24b |
Recent financial health updates
Recent updates
Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?
Oct 22
With Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) It Looks Like You'll Get What You Pay For
Aug 12Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly
Jun 23Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321
May 21Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today
Apr 12Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%
Mar 04Financial Position Analysis
Short Term Liabilities: 300705's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥377.7M).
Long Term Liabilities: 300705's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥479.9M).
Debt to Equity History and Analysis
Debt Level: 300705 has more cash than its total debt.
Reducing Debt: 300705's debt to equity ratio has reduced from 17% to 15.4% over the past 5 years.
Debt Coverage: 300705's debt is well covered by operating cash flow (175.8%).
Interest Coverage: 300705's interest payments on its debt are well covered by EBIT (44.8x coverage).